- Home
- TPCS vs GRCE Comparison
TPCS vs GRCE Comparison
Compare TPCS & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- GRCE
- Stock Information
- Founded
- TPCS 1956
- GRCE 2002
- Country
- TPCS United States
- GRCE United States
- Employees
- TPCS N/A
- GRCE N/A
- Industry
- TPCS Metal Fabrications
- GRCE
- Sector
- TPCS Industrials
- GRCE
- Exchange
- TPCS Nasdaq
- GRCE NYSE
- Market Cap
- TPCS 27.2M
- GRCE 34.1M
- IPO Year
- TPCS N/A
- GRCE N/A
- Fundamental
- Price
- TPCS $2.60
- GRCE $2.34
- Analyst Decision
- TPCS
- GRCE Strong Buy
- Analyst Count
- TPCS 0
- GRCE 1
- Target Price
- TPCS N/A
- GRCE $12.00
- AVG Volume (30 Days)
- TPCS 48.3K
- GRCE 120.7K
- Earning Date
- TPCS 01-21-2025
- GRCE 02-13-2025
- Dividend Yield
- TPCS N/A
- GRCE N/A
- EPS Growth
- TPCS N/A
- GRCE N/A
- EPS
- TPCS N/A
- GRCE N/A
- Revenue
- TPCS $33,182,059.00
- GRCE N/A
- Revenue This Year
- TPCS N/A
- GRCE N/A
- Revenue Next Year
- TPCS N/A
- GRCE N/A
- P/E Ratio
- TPCS N/A
- GRCE N/A
- Revenue Growth
- TPCS 6.44
- GRCE N/A
- 52 Week Low
- TPCS $2.16
- GRCE $2.13
- 52 Week High
- TPCS $5.95
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- TPCS 36.02
- GRCE N/A
- Support Level
- TPCS $2.68
- GRCE N/A
- Resistance Level
- TPCS $3.00
- GRCE N/A
- Average True Range (ATR)
- TPCS 0.25
- GRCE 0.00
- MACD
- TPCS -0.00
- GRCE 0.00
- Stochastic Oscillator
- TPCS 48.89
- GRCE 0.00
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.